OPPM

Opus Point Partners Management Portfolio holdings

AUM $46.9M
This Quarter Return
-17.38%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$37.2M
AUM Growth
-$4.65M
Cap. Flow
+$1.62M
Cap. Flow %
4.34%
Top 10 Hldgs %
68.93%
Holding
49
New
2
Increased
9
Reduced
21
Closed
10

Top Buys

1
IBB icon
iShares Biotechnology ETF
IBB
$12.1M
2
LABU icon
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$2.28M
3
EXEL icon
Exelixis
EXEL
$102K
4
BLUE
bluebird bio
BLUE
$78.3K
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
$55.1K

Top Sells

1
TSRO
TESARO, Inc.
TSRO
$3.68M
2
CLVS
Clovis Oncology, Inc.
CLVS
$2.42M
3
MEIP icon
MEI Pharma
MEIP
$1.55M
4
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
$1.14M
5
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
$891K

Sector Composition

1 Healthcare 61.52%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRL icon
26
Charles River Laboratories
CRL
$7.76B
$302K 0.66%
2,665
-161
-6% -$18.2K
UTHR icon
27
United Therapeutics
UTHR
$17.6B
$290K 0.64%
2,664
-141
-5% -$15.3K
GILD icon
28
Gilead Sciences
GILD
$140B
$289K 0.64%
4,618
+85
+2% +$5.32K
BLUE
29
DELISTED
bluebird bio
BLUE
$271K 0.6%
211
+61
+41% +$78.3K
TECH icon
30
Bio-Techne
TECH
$8.07B
$255K 0.56%
7,048
-1,920
-21% -$69.5K
ACAD icon
31
Acadia Pharmaceuticals
ACAD
$4.33B
$241K 0.53%
14,899
-5,929
-28% -$95.9K
AGIO icon
32
Agios Pharmaceuticals
AGIO
$2B
$236K 0.52%
5,115
-9,987
-66% -$461K
RARE icon
33
Ultragenyx Pharmaceutical
RARE
$3.03B
$232K 0.51%
5,339
-795
-13% -$34.5K
ALKS icon
34
Alkermes
ALKS
$4.9B
$224K 0.49%
7,605
-17,637
-70% -$519K
NBIX icon
35
Neurocrine Biosciences
NBIX
$13.6B
$213K 0.47%
2,986
-405
-12% -$28.9K
CKPT
36
DELISTED
Checkpoint Therapeutics
CKPT
$205K 0.45%
11,276
– –
FBIO icon
37
Fortress Biotech
FBIO
$88.1M
$201K 0.44%
15,602
– –
PGEN icon
38
Precigen
PGEN
$1.4B
$177K 0.39%
27,109
+3,329
+14% +$21.7K
SCTL
39
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$81K 0.18%
12,659
– –
AKBA icon
40
Akebia Therapeutics
AKBA
$827M
– –
-45,004
Closed -$397K
AXSM icon
41
Axsome Therapeutics
AXSM
$6.11B
– –
-120,150
Closed -$415K
MEIP icon
42
MEI Pharma
MEIP
$151M
– –
-18,000
Closed -$1.55M
ADMS
43
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
– –
-44,500
Closed -$891K
CFRX
44
DELISTED
ContraFect Corporation
CFRX
– –
-84
Closed -$140K
ACHN
45
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
– –
-308,569
Closed -$1.14M
TSRO
46
DELISTED
TESARO, Inc.
TSRO
– –
-94,300
Closed -$3.68M
SCYX icon
47
SCYNEXIS
SCYX
$35.2M
– –
-2,997
Closed -$36K
PRTK
48
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-18,000
Closed -$175K
CLVS
49
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-82,430
Closed -$2.42M
1
2